期刊
JOURNAL OF INFECTIOUS DISEASES
卷 211, 期 5, 页码 780-790出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiu515
关键词
HIV; immune nonresponders to ART; microbial translocation; immune activation; inflammation; rifaximin
资金
- National Institute of Health [AI068636, AI068634, AI069452, A1025439, AI069424, AI069447, AI069419, AI069532, AI069470, AI069494, AI069511-08, AI069439, AI069418, AI069556]
- National Institute of Health. [AI069477, AI069501, AI069471, AI069412, AI069502, AI69501, AI069423, AI069415, AI069481, AI069534, AI069503, AI069432, TR001082, RR024160, TR001070, TR000439, TR001111, Al050404, AI073961, AI50410, AI045008]
Background. Rifaximin, a nonabsorbable antibiotic that decreases lipopolysaccharide (LPS) in cirrhotics, may decrease the elevated levels of microbial translocation, T-cell activation and inflammation in human immunodeficiency virus (HIV)-positive immune nonresponders to antiretroviral therapy (ART). Methods. HIV-positive adults receiving ART for >= 96 weeks with undetectable viremia for >= 48 weeks and CD4(+) T-cell counts <350 cells/mm(3) were randomized 2:1 to rifaximin versus no study treatment for 4 weeks. T-cell activation, LPS, and soluble CD14 were measured at baseline and at weeks 2, 4, and 8. Wilcoxon rank sum tests compared changes between arms. Results. Compared with no study treatment (n = 22), rifaximin (n = 43) use was associated with a significant difference between study arms in the change from baseline to week 4 for CD8(+)T-cell activation (median change, 0.0% with rifaximin vs +0.6% with no treatment; P=.03). This difference was driven by an increase in the no-study-treatment arm because there was no significant change within the rifaximin arm. Similarly, although there were significant differences between study arms in change from baseline to week 2 for LPS and soluble CD14, there were no significant changes within the rifaximin arm. Conclusions. In immune nonresponders to ART, rifaximin minimally affected microbial translocation and CD8(+)T-cell activation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据